Wang Chao, Lassi Nicholas, Zhang Xiaohan, Sharma Vinay
Guanghua Law School, Zhejiang University, Hangzhou 310008, China.
Research Center for Socialism with Chinese Characteristics, Zhejiang University, Hangzhou 310058, China.
Int J Environ Res Public Health. 2022 Feb 12;19(4):2074. doi: 10.3390/ijerph19042074.
The rise of the synthetic opioid epidemic has time and time again brought criticism on China and India, the world's two main producers of fentanyl and its chemical precursors. In the past few years, the two countries have attempted to strengthen regulations over fentanyl production and distribution, though its effects on global drug governance remain under scrutiny. This study used qualitative and comparative methods to investigate the current regulatory landscape for fentanyl, including its efficiency and potential loopholes in China and India. It concludes that although both China and India are actively and significantly attempting to step away from the global fentanyl supply chain, these efforts remain ineffective due to institutional loopholes, namely inadequate legislation and fragmented regulatory structures. From insights gained on global drug governance, we recommend a binding international convention concentrated on controlling fentanyl and its related substances, with further bilateral and multilateral cooperation among states as necessary complementation.
合成阿片类药物流行的加剧一次又一次地引发了对中国和印度的批评，这两个国家是芬太尼及其化学前体的全球两大主要生产国。在过去几年里，两国试图加强对芬太尼生产和分销的监管，不过其对全球毒品治理的影响仍在审视之中。本研究采用定性和比较方法，调查了芬太尼当前的监管状况，包括其在中国和印度的监管效率及潜在漏洞。研究得出结论，尽管中国和印度都在积极且大力地试图退出全球芬太尼供应链，但由于制度漏洞，即立法不足和监管结构分散，这些努力仍然无效。基于从全球毒品治理中获得的见解，我们建议制定一项专门管控芬太尼及其相关物质的具有约束力的国际公约，并在必要时由各国进一步开展双边和多边合作作为补充。
